Literature DB >> 17476347

A cytokine-mediated link between innate immunity, inflammation, and cancer.

Wan-Wan Lin1, Michael Karin.   

Abstract

It has been established that cancer can be promoted and/or exacerbated by inflammation and infections. Indeed, chronic inflammation orchestrates a tumor-supporting microenvironment that is an indispensable participant in the neoplastic process. The mechanisms that link infection, innate immunity, inflammation, and cancer are being unraveled at a fast pace. Important components in this linkage are the cytokines produced by activated innate immune cells that stimulate tumor growth and progression. In addition, soluble mediators produced by cancer cells recruit and activate inflammatory cells, which further stimulate tumor progression. However, inflammatory cells also produce cytokines that can limit tumor growth. Here we provide an overview of the current understanding of the role of inflammation-induced cytokines in tumor initiation, promotion, and progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17476347      PMCID: PMC1857251          DOI: 10.1172/JCI31537

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  125 in total

Review 1.  The TREM receptor family and signal integration.

Authors:  Julia Klesney-Tait; Isaiah R Turnbull; Marco Colonna
Journal:  Nat Immunol       Date:  2006-12       Impact factor: 25.606

Review 2.  IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.

Authors:  Jun-Li Luo; Hideaki Kamata; Michael Karin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.

Authors:  E Tartour; F Fossiez; I Joyeux; A Galinha; A Gey; E Claret; X Sastre-Garau; J Couturier; V Mosseri; V Vives; J Banchereau; W H Fridman; J Wijdenes; S Lebecque; C Sautès-Fridman
Journal:  Cancer Res       Date:  1999-08-01       Impact factor: 12.701

4.  T cells require TRAIL for optimal graft-versus-tumor activity.

Authors:  Cornelius Schmaltz; Onder Alpdogan; Barry J Kappel; Stephanie J Muriglan; Jimmy A Rotolo; Jennifer Ongchin; Lucy M Willis; Andrew S Greenberg; Jeffrey M Eng; James M Crawford; George F Murphy; Hideo Yagita; Henning Walczak; Jacques J Peschon; Marcel R M van den Brink
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

5.  CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

Authors:  Susan E Erdman; Jane J Sohn; Varada P Rao; Prashant R Nambiar; Zhongming Ge; James G Fox; David B Schauer
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

6.  Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo.

Authors:  Mei-Ling Chen; Mikaël J Pittet; Leonid Gorelik; Richard A Flavell; Ralph Weissleder; Harald von Boehmer; Khashayarsha Khazaie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

Review 7.  The role of interleukin-1beta and other potential genetic markers as indicators of gastric cancer risk.

Authors:  Esther Troost; Georgina L Hold; Malcolm G Smith; Wong-Ho Chow; Charles S Rabkin; Kenneth E L McColl; Emad M El-Omar
Journal:  Can J Gastroenterol       Date:  2003-06       Impact factor: 3.522

8.  CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice.

Authors:  Susan E Erdman; Varada P Rao; Theofilos Poutahidis; Melanie M Ihrig; Zhongming Ge; Yan Feng; Michal Tomczak; Arlin B Rogers; Bruce H Horwitz; James G Fox
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

9.  Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.

Authors:  François Ghiringhelli; Pierre E Puig; Stephan Roux; Arnaud Parcellier; Elise Schmitt; Eric Solary; Guido Kroemer; François Martin; Bruno Chauffert; Laurence Zitvogel
Journal:  J Exp Med       Date:  2005-09-26       Impact factor: 14.307

10.  Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.

Authors:  Craig A Murphy; Claire L Langrish; Yi Chen; Wendy Blumenschein; Terrill McClanahan; Robert A Kastelein; Jonathon D Sedgwick; Daniel J Cua
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

View more
  641 in total

Review 1.  BCG response prediction with cytokine gene variants and bladder cancer: where we are?

Authors:  Dinesh Kumar Ahirwar; Parmeet Kaur Manchanda; Rama Devi Mittal; Hemant K Bid
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-20       Impact factor: 4.553

2.  An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas.

Authors:  Xueyan Zhao; Travis Laver; Suk W Hong; George B Twitty; Annelies Devos; Marijke Devos; Etty N Benveniste; Susan E Nozell
Journal:  J Neurooncol       Date:  2011-01-30       Impact factor: 4.130

Review 3.  Role of TLR2-dependent inflammation in metastatic progression.

Authors:  Sunhwa Kim; Michael Karin
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

4.  Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.

Authors:  Gabriela Schiechl; Bernhard Bauer; Ivan Fuss; Sven A Lang; Christian Moser; Petra Ruemmele; Stefan Rose-John; Markus F Neurath; Edward K Geissler; Hans-Jürgen Schlitt; Warren Strober; Stefan Fichtner-Feigl
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

Review 5.  Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB.

Authors:  Thorsten Hagemann; Subhra K Biswas; Toby Lawrence; Antonio Sica; Claire E Lewis
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

Review 6.  Clinical proteomics identifies potential biomarkers in Helicobacter pylori for gastrointestinal diseases.

Authors:  Chun-Hao Huang; Shyh-Horng Chiou
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

7.  MUC1 in macrophage: contributions to cigarette smoke-induced lung cancer.

Authors:  Xiuling Xu; Mabel T Padilla; Bilan Li; Alexandria Wells; Kosuke Kato; Carmen Tellez; Steven A Belinsky; Kwang Chul Kim; Yong Lin
Journal:  Cancer Res       Date:  2013-11-26       Impact factor: 12.701

8.  Influence of genetic variants of gamma interferon, interleukins 10 and 12 on Visceral Leishmaniasis in an endemic area, Iran.

Authors:  Mehdi Kalani; Maral Choopanizadeh; Manoochehr Rasouli
Journal:  Pathog Glob Health       Date:  2019-01-15       Impact factor: 2.894

9.  In vitro cytokine release profile: predictive value for metastatic potential in head and neck squamous cell carcinomas.

Authors:  Omar Shkeir; Maria Athanassiou-Papaefthymiou; Martian Lapadatescu; Petros Papagerakis; Michael J Czerwinski; Carol R Bradford; Thomas E Carey; Mark E P Prince; Gregory T Wolf; Silvana Papagerakis
Journal:  Head Neck       Date:  2013-01-16       Impact factor: 3.147

10.  The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis.

Authors:  Grace Y Chen; Michael H Shaw; Gloria Redondo; Gabriel Núñez
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.